FDA Draws The Line On Wrinkle Reduction Claims In Warning Letter
This article was originally published in The Rose Sheet
Executive Summary
Wrinkle reduction claims for University Medical Products' Face Lift Collagen 5 products reflect changes to the structure or function of the body, necessitating new drug approval for the products, FDA states in a 1warning letter recently posted to its Web site
You may also be interested in...
Is StriVectin Better Than Botox? Not Without NDA Approval, FDA Says
Klein-Becker's signature statement for StriVectin-SD anti-aging cream - "Better than Botox?" - constitutes a structure/function claim that would require the product to be regulated as a drug, the agency states in a 1warning letter recently posted on its Web site
Is StriVectin Better Than Botox? Not Without NDA Approval, FDA Says
Klein-Becker's signature statement for StriVectin-SD anti-aging cream - "Better than Botox?" - constitutes a structure/function claim that would require the product to be regulated as a drug, the agency states in a 1warning letter recently posted on its Web site
NAD Takes Initiative In Reviews Of Anti-Aging, Cellulite Claims In 2004
Skin care marketers are likely to step up challenges to competitors' ad claims regarding wrinkle reduction as the market for anti-aging products grows, according to David Mallen, Assistant Director and Senior Attorney at the National Advertising Division of the Council of Better Business Bureaus